← Leaderboards
Sherin S Abdel-Meguid
Shifa Biomedical Corporation
$2,093,739
Attributed
$2,093,739
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $681.3K · FY2006–11$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$2,093,739 · 4
By mechanism
R44$1,336,676 · 1
R43$757,063 · 3
Top collaborators
No co-investigators on record.
Most similar at Shifa Biomedical Corporation
Same institution · by research overlap
- Nabil A Elshourbagy$7,123,349
- Arnold T Hagler$574,710
Others in their field
Top investigators on “Screening Procedure”
- David Heimbrook · Leidos Biomedical Research, Inc.$128,277,736
- Peter B. Gilbert · Fred Hutchinson Cancer Center$111,689,164
- Michael W Weiner · Northern California Institute Res &Educ$92,204,126
- Elizabeth A Thom · George Washington University$78,533,902
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,381,339
- Gita Ramjee · Medical Research Council Of South Africa$60,925,220
Research focus
Screening ProcedureCatalytic DomainLeadRegulationStructureCause Of DeathDatabasesEnzyme PrecursorsPreventProgramsDockingComputersBaseVirtualAdverse EffectsBiologicalBloodDrug MarketPharmaceutical PreparationsPlasmaComputer SimulationClinical DataCodeCholesterol Homeostasis
Grant awards (5)
Structure-Based Search for Novel Antihypercholestrolemic Agent$655,327
R44 · FY2011 · HL · contact PI
Structure-Based Search for Novel Antihypercholestrolemic Agent$681,349
R44 · FY2010 · HL · contact PI
Structure-Based Search for Novel Antihypercholestrolemic Agents$258,966
R43 · FY2008 · HL · contact PI
Search for Antithrombotic Compounds to Overcome Adverse Effects of Current Drugs$256,345
R43 · FY2008 · HL · contact PI
Search for Anti-Androgen Compounds to Overcome Resistance of Current Drugs$241,752
R43 · FY2006 · CA · contact PI